Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureGuillaume Lefèvre, Florence Roufosse, Giacomo Emmi, Emmanuel Ledoult, Jean‐Emmanuel Kahn
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Proposed Refined Diagnostic Criteria and Classification of Eosinophil Disorders and Related Syndromes
10.1111/all.15544 · 2023
Medical Algorithm: Diagnosis and Treatment of Hypereosinophilic Syndrome
10.1111/all.14368 · 2020
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort
10.1111/all.16463 · 2025
Efficacy and Safety of Mepolizumab in Hypereosinophilic Syndrome: A Phase III, Randomized, Placebo‐Controlled Trial
10.1016/j.jaci.2020.08.037 · 2020
10.1038/s41591-026-04425-3
10.1038/s41591-026-04425-3
Eosinophilia Associated With CD3‐CD4+ T Cells: Characterization and Outcome of a Single‐Center Cohort of 26 Patients
10.3389/fimmu.2020.01765 · 2020
JAK Inhibition for CD3‐ CD4+ Lymphocytic‐Variant Hypereosinophilic Syndrome
10.1016/j.clim.2023.109275 · 2023
Targeting CCR4 With Mogamulizumab in Refractory CD3‐CD4+ Lymphocytic‐Variant Hypereosinophilic Syndrome
10.3324/haematol.2023.284429 · 2024
How I Diagnose and Treat Myeloid/Lymphoid Neoplasms With Tyrosine Kinase Gene Fusions
10.1182/blood.2023022417 · 2025
No additional external references are available.